Search results for "Substance"

showing 10 items of 1728 documents

FRI0318 Health care resource utilisation (HCRU) and cost analyses of systemic lupus erythematosus (SLE) as a function of disease severity: analysis o…

2018

Background SLE is a severe, chronic autoimmune disease of the connective tissue involving multiple organ systems. Understanding the economic burden of SLE in the context of disease severity is important when considering new therapeutic options. Objectives HCRU and costs associated with SLE were examined retrospectively using anonymized data from a German Sickness Fund database. Methods Real-world claims for adult (≥18 years old) patients (pts) with SLE from a German Sickness Fund database of company health insurance schemes were analysed. HCRU and costs were assessed annually for 2009–2014 for pts diagnosed with SLE in 2009 and validated using repeated SLE-related claims, co-diagnosis codes…

medicine.medical_specialtybusiness.industryIncidence (epidemiology)SpecialtyContext (language use)macromolecular substancesDisease severityInternal medicineClaims dataHealth caremedicineMedical prescriptionskin and connective tissue diseasesbusinessOrgan systemFRIDAY, 15 JUNE 2018
researchProduct

2015

Quality of life (QoL) is increasingly recognized as central to the broad construct of recovery in patients with substance use disorders (SUD). However, few longitudinal studies have evaluated changes in QoL after SUD treatment and included patients with SUD that were compulsorily hospitalized. This study aimed to describe QoL among in-patients admitted either voluntarily or compulsorily to hospitalization and to examine patterns and predictors of QoL at admission and at 6 months post treatment. This prospective study followed 202 hospitalized patients with SUD that were admitted voluntarily (N=137) or compulsorily (N=65). A generic QoL questionnaire (QoL-5) was used to assess QoL domains. R…

medicine.medical_specialtybusiness.industryPublic Health Environmental and Occupational HealthSymptom burdenGeneral Medicinemedicine.diseasehumanitiesConfidence intervalSubstance abuseQuality of lifePhysical therapyMedicineIn patientSubstance usePost treatmentbusinessProspective cohort studyHealth and Quality of Life Outcomes
researchProduct

Severe Chronic Allergic (and Related) Diseases: A Uniform Approach – A MeDALL – GA<sup>2</sup>LEN – ARIA Position Paper

2012

Concepts of disease severity, activity, control and responsiveness to treatment are linked but different. Severity refers to the loss of function of the organs induced by the disease process or to the occurrence of severe acute exacerbations. Severity may vary over time and needs regular follow-up. Control is the degree to which therapy goals are currently met. These concepts have evolved over time for asthma in guidelines, task forces or consensus meetings. The aim of this paper is to generalize the approach of the uniform definition of severe asthma presented to WHO for chronic allergic and associated diseases (rhinitis, chronic rhinosinusitis, chronic urticaria and atopic dermatitis) in …

medicine.medical_specialtybusiness.industryPublic healthImmunologymacromolecular substancesGeneral MedicineAtopic dermatitismedicine.disease3. Good health03 medical and health sciences0302 clinical medicine030228 respiratory systemDisease severityEpidemiologyImmunologymedicinePhysical therapyImmunology and AllergyPosition paperDisease process030212 general & internal medicineIntensive care medicinebusinessChronic urticariaAsthmaInternational Archives of Allergy and Immunology
researchProduct

Unmet needs in the management of schizophrenia

2014

Studies on unmet needs during the last decades have played a significant role in the development and dissemination of evidence-based community practices for persistent schizophrenia and other severe mental disorders. This review has thoroughly considered several blocks of unmet needs, which are frequently related to schizophrenic disorders. Those related to health have been the first block to be considered, in which authors have examined the frequent complications and comorbidities found in schizophrenia, such as substance abuse and dual diagnosis. A second block has been devoted to psychosocial and economic needs, especially within the field of recovery of the persistently mentally ill. Wi…

medicine.medical_specialtybusiness.industrySchizophrenia (object-oriented programming)Psychological interventionunmet needsCapacity buildingReviewSevere mental disordersmedicine.diseaseMental healthUnmet needsSubstance abuseschizophreniaPsychiatry and Mental healthManagement of schizophreniamedicineSchizophreniaDual diagnosissevere mental disordersPsychiatrybusinessNeedsPsychosocialBiological PsychiatryneedsNeuropsychiatric Disease and Treatment
researchProduct

A time-geographic approach for visualizing the paths of intervention for persons with severe mental illness

2017

Living conditions for persons with severe mental illness (SMI) in Sweden have changed dramatically in recent decades, mainly due to the closure of mental hospitals in the 1990s and the subsequent d ...

medicine.medical_specialtybusiness.industryeducationGeography Planning and DevelopmentPsychological interventionTime geographymacromolecular substancesMental illnessmedicine.disease030227 psychiatry03 medical and health sciences0302 clinical medicineIntervention (counseling)mental disordersMedicinesense organs030212 general & internal medicineClosure (psychology)skin and connective tissue diseasesbusinessPsychiatryGeografiska Annaler: Series B, Human Geography
researchProduct

Evaluation of Safety, Tolerability and Efficacy of Temsirolimus in Patients with Relapsed or Refractory Mantle Cell Lymphoma (REL/REFR MCL) in the Us…

2012

ABSTRACT Background Temsirolimus (TEMS), an mTOR-inhibitor, is approved the EU for the treatment of patients (pts) with relapsed or refractory MCL (rel/refr). A pivotal study demonstrated significantly longer progression free survival with TEMS (175mg weekly for 3 weeks followed by 75mg weekly) in rel/refr MCL pts compared to investigatoŕs choice therapy (4.8 mo vs 1.9 mo; P = .0009). To better identify safety and efficacy of TEMS in an unselected patient population during clinical routine a prospective non-interventional study with TEMS in rel/refr MCL-pts was started. Here we report on interim results of the study. Methods A registry for rel/refr MCL pts treated with TEMS was started in G…

medicine.medical_specialtybusiness.industrymacromolecular substancesHematologyTemsirolimusOncologyTolerabilityRefractoryInternal medicinemedicineRefractory Mantle Cell LymphomaIn patientProgression-free survivalLeukocytosismedicine.symptombusinessAdverse effectmedicine.drugAnnals of Oncology
researchProduct

2019

This study investigated the use of performance-enhancing substances in recreational triathletes who were competing in German races at distances ranging from super-sprint to long-distance, as per the International Triathlon Union. The use of legal drugs and over-the-counter supplements over the previous year, painkillers over the previous 3 months, and the potential three-month prevalence of physical doping and or cognitive doping in this group were assessed via an anonymous questionnaire. The Randomised Response Technique (RRT) was implemented for sensitive questions regarding “prescription drugs […] for the purpose of performance enhancement […] only available at a pharmacy or on the black…

medicine.medical_specialtybusiness.industrytechnology industry and agriculturePhysical Therapy Sports Therapy and RehabilitationPharmacyCognition030229 sport sciencesConfidence intervallanguage.human_languageGerman03 medical and health sciences0302 clinical medicinelanguagePhysical therapyMedicineOrthopedics and Sports Medicine030212 general & internal medicineSubstance useMedical prescriptionbusinessPerformance enhancementhuman activitiesRecreationSports
researchProduct

New Perspective in Atrial Fibrillation

2020

International audience; Despite a large number of publications on this subject, the pathophysiological mechanisms involved in atrial fibrillation (AF) onset and recurrence are uncertain [...]

medicine.medical_specialtyeducationMEDLINElcsh:Medicinemacromolecular substances030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicine0502 economics and businessmedicineIntensive care medicine[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologybusiness.industrylcsh:R05 social sciencesPerspective (graphical)Subject (documents)Atrial fibrillationGeneral Medicinemedicine.disease3. Good healthn/aEditorial050211 marketingbusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

The Association Between Smoking Status and Depression in the General Population of Latvia

2015

Introduction Tobacco dependence is the most common substance use disorder in people with mental illness. Smoking and depression are firmly associated and both represent major health problems. Aim The aim of the study was to assess association between smoking status and 12-months depression in representative sample of the general Latvian population. Methods The study was a part of health monitoring survey, a collaborative project between Baltic States and Finland, which monitors health related behaviours; the questionnaire included structured interview and depressive module of the Mini International Neuropsychiatric Interview. Descriptive statistics and binary regression model were applied. …

medicine.medical_specialtyeducation.field_of_studyDescriptive statisticsbusiness.industryPopulationmedicine.diseaseMental illnessSubstance abusePsychiatry and Mental healthStructured interviewmedicineAssociation (psychology)PsychiatryeducationbusinessDepression (differential diagnoses)DemographyMini-international neuropsychiatric interviewEuropean Psychiatry
researchProduct

Changes in the Expression of Tachykinin Receptors in the Rat Uterus During the Course of Pregnancy1

2001

In the mammalian female reproductive tract, tachykinin neuropeptides, such as substance P (SP), are localized to a population of sensory fibers and their precise physiological role is still unknown. The aim of the present study was to characterize the population of tachykinin receptors in the pregnant rat uterus and to assess their regulation during the course of pregnancy and after delivery. The expression of the tachykinin NK(1) receptor (NK(1)R), the tachykinin NK(2) receptor (NK(2)R), and the tachykinin NK(3) receptor (NK(3)R) in uteri from rats at different stages of pregnancy and on Day 1 postpartum was investigated by using a semiquantitative reverse transcription-polymerase chain re…

medicine.medical_specialtyeducation.field_of_studymedicine.drug_classPopulationPhosphoramidonUterusNeuropeptideSubstance PCell BiologyGeneral MedicineBiologychemistry.chemical_compoundmedicine.anatomical_structureEndocrinologyReproductive MedicinechemistryEstrogenInternal medicinemedicineeducationTachykinin receptorReceptorBiology of Reproduction
researchProduct